Chinese scientists would select 30 volunteers to undergo clinical(临床的) tests for a SARS vaccine, said sources with
China's SARS vaccine research team.
The team has drawn up an implementation(执行) plan to conduct clinical research for an effective SARS vaccine.
The first phase will last for three months in Beijing, Guangdong Province or neighboring Guangxi Zhuang Autonomous Region.
The volunteers will comprise 15 men and 15 women aged from 18 to 40. The volunteers must pass a medical examination and clinical observation, and their body temperatures must not be higher than 37 deGREes centigrade before vaccination.
The vaccine was found safe and effective in experiments on animals, including the rhesus monkey(恒河猴). The first phase test is designed to see if it is safe and effective for humans.
The vaccination could cause minor side effects such as low fever and pain. But these symptoms were expected to disappear naturally without medical treatment.
A committee would be set up to protect the rights of the volunteers, who can withdraw from the test at any time.
